<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0100">
 <label>20</label>
 <element-citation publication-type="journal" id="rf0090">
  <person-group person-group-type="author">
   <name>
    <surname>Beigel</surname>
    <given-names>J.H.</given-names>
   </name>
   <name>
    <surname>Aga</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Elie-Turenne</surname>
    <given-names>M.C.</given-names>
   </name>
   <name>
    <surname>Cho</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Tebas</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Clark</surname>
    <given-names>C.L.</given-names>
   </name>
  </person-group>
  <article-title>Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial</article-title>
  <source>Lancet Respir Med</source>
  <volume>7</volume>
  <year>2019</year>
  <fpage>941</fpage>
  <lpage>950</lpage>
  <pub-id pub-id-type="pmid">31582360</pub-id>
 </element-citation>
</ref>
